Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: A case report - 11/05/12
Abstract |
A patient with widespread in situ squamous cell carcinoma of the glans penis was successfully managed with topical application of 5% imiquimod cream. Therapy with topical immune response modifiers may prove beneficial in cases of superficial cutaneous carcinoma and may, if future studies confirm our findings, play a role in settings in which more destructive techniques may result in cosmetic defects or functional impairment. The use of imiquimod for intraepithelial squamous cell carcinoma of the anogenital area seems particularly logical because of the strong correlation between this neoplasm and infection with human papillomavirus. (J Am Acad Dermatol 2002;47:S225-8.)
Le texte complet de cet article est disponible en PDF.Plan
Funding sources: None. |
|
This article is part of a supplement sponsored by 3M Pharmaceuticals. |
|
Disclosures: Drs Orengo and Rosen are members of the Speakers' Bureau for the manufacturer of imiquimod cream (3M Pharmaceuticals). Dr Guill has no conflict of interest to disclose. |
|
Reprints are not available from authors. |
Vol 47 - N° 4S
P. S225-S228 - octobre 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?